| Summary of Net Revenue, Cost of Sales, Operating Profit, Depreciation and Amortization, Interest Expense and Assets by Segment |
The following table shows, by segment: net revenue, cost of sales, operating profit, depreciation and amortization, interest expense, and assets for the years ended November 30, 2023 and November 30, 2022:
|
|
|
|
|
|
|
|
|
|
|
For the years ended November 30, |
|
|
|
2023 |
|
|
2022 |
|
Net revenue: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
30,796,091 |
|
|
$ |
29,771,123 |
|
PrepaCyte CB |
|
|
66,456 |
|
|
|
104,000 |
|
Public cord blood banking |
|
|
481,148 |
|
|
|
461,626 |
|
Total net revenue |
|
$ |
31,343,695 |
|
|
$ |
30,336,749 |
|
Cost of sales: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
7,268,724 |
|
|
$ |
7,095,113 |
|
PrepaCyte CB |
|
|
35,490 |
|
|
|
100,715 |
|
Public cord blood banking |
|
|
1,138,096 |
|
|
|
1,596,530 |
|
Total cost of sales |
|
$ |
8,442,310 |
|
|
$ |
8,792,358 |
|
Operating (loss) profit: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
(7,911,698 |
) |
|
$ |
5,185,305 |
|
PrepaCyte CB |
|
|
3,188 |
|
|
|
(24,493 |
) |
Public cord blood banking |
|
|
(4,395,522 |
) |
|
|
(1,136,345 |
) |
Total operating (loss) profit |
|
$ |
(12,304,032 |
) |
|
$ |
4,024,467 |
|
Depreciation and amortization: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
1,095,009 |
|
|
$ |
1,090,309 |
|
PrepaCyte CB |
|
|
27,778 |
|
|
|
27,778 |
|
Public cord blood banking |
|
|
1,441 |
|
|
|
1,441 |
|
Total depreciation and amortization |
|
$ |
1,124,228 |
|
|
$ |
1,119,528 |
|
Interest expense: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
1,236,794 |
|
|
$ |
1,521,767 |
|
PrepaCyte CB |
|
|
— |
|
|
|
— |
|
Public cord blood banking |
|
|
— |
|
|
|
— |
|
Total interest expense |
|
$ |
1,236,794 |
|
|
$ |
1,521,767 |
|
The following table shows the assets by segment as of November 30, 2023 and November 30, 2022:
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
As of |
|
|
|
November 30, 2023 |
|
|
November 30, 2022 |
|
Assets: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell
service |
|
$ |
55,471,149 |
|
|
$ |
54,849,697 |
|
PrepaCyte CB |
|
|
148,040 |
|
|
|
176,546 |
|
Public cord blood banking |
|
|
5,601,581 |
|
|
|
9,861,811 |
|
Total assets |
|
$ |
61,220,770 |
|
|
$ |
64,888,054 |
|
|